Improving the Adverse Cardiovascular Prognosis of Type 2 Diabetes

Mayo Clinic Proceedings - Netherlands
doi 10.4065/74.2.171
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Preventing Major Adverse Cardiovascular Events by SGLT-2 Inhibition in Patients With Type 2 Diabetes: The Role of Kidney

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2020English

Type 2 Diabetes and Cardiovascular Risk Factors

Current Medical Research and Opinion
Medicine
2011English

Type 2 Diabetes and Cardiovascular Disease: Reducing the Risk

Journal of Managed Care Pharmacy
2007English

Sulfonylureas and Cardiovascular Complications of Type 2 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Cardiovascular Risk in Patients With Type 2 Diabetes

CMAJ
Medicine
2005English

Molecular Clocks, Type 2 Diabetes and Cardiovascular Disease

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2008English

The Use of Cardiovascular Magnetic Resonance to Identify Adverse Cardiac Prognosis

Journal of the American College of Cardiology
Cardiovascular MedicineCardiology
2010English

Cardiovascular Safety of Non-Insulin Pharmacotherapy for Type 2 Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2017English

Alteration of Cardiovascular Autonomic Activity in Type 2 Diabetes Mellitus

International Journal of Research in Medical Sciences
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy